Search research articles
Contact Us
Filters
Showing results (71-80 of 212) with videos related to
Page
of 22
Sort By:
Breast Cancer Research and Treatment
|
March 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study
Shanu Modi, Suyuan Zhang, Danalyn Byng, et al.
Cancer Reports (Hoboken, N.J.)
|
October 27, 2022
Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study
Michel Fabbro, William Jacot, Marta Jarlier, et al.
International Journal of Cancer
|
July 28, 2016
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
American Journal of Clinical Oncology
|
January 1, 2010
Phase II trial of dose dense docetaxel followed by FEC100 as neoadjuvant chemotherapy in patients with operable breast cancer
William Jacot, Frédéric Bibeau, Sophie Gourgou-Bourgade, et al.
Cancer Management and Research
|
December 19, 2019
Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
Marie Alexandre, Aurélie Maran-Gonzalez, Marie Viala, et al.
BMC Cancer
|
November 22, 2025
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer
Constance Delaby, Anas Al Herk, Christophe Hirtz, et al.
BMC Cancer
|
July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Cancers
|
March 6, 2021
Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Florence Boissière-Michot, Ghita Chabab, Caroline Mollevi, et al.
Annals of Surgical Oncology
|
July 17, 2015
Oncoplastic Resection of Breast Cancers Located in the Lower-Inner or Lower-Outer Quadrant with the Modified McKissock Mammaplasty Technique
Pierre-Emmanuel Colombo, Marine Lefèvre, Laure Delmond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 2, 2008
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes
William Jacot, Ludovic Lhermitte, Nadège Dossat, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 212) with videos related to
Sort By:
Page
of 22
Breast Cancer Research and Treatment
|
March 25, 2025
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study
Shanu Modi, Suyuan Zhang, Danalyn Byng, et al.
Cancer Reports (Hoboken, N.J.)
|
October 27, 2022
Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study
Michel Fabbro, William Jacot, Marta Jarlier, et al.
International Journal of Cancer
|
July 28, 2016
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
American Journal of Clinical Oncology
|
January 1, 2010
Phase II trial of dose dense docetaxel followed by FEC100 as neoadjuvant chemotherapy in patients with operable breast cancer
William Jacot, Frédéric Bibeau, Sophie Gourgou-Bourgade, et al.
Cancer Management and Research
|
December 19, 2019
Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?
Marie Alexandre, Aurélie Maran-Gonzalez, Marie Viala, et al.
BMC Cancer
|
November 22, 2025
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer
Constance Delaby, Anas Al Herk, Christophe Hirtz, et al.
BMC Cancer
|
July 9, 2016
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
Amélie Darlix, Pierre-Jean Lamy, Evelyne Lopez-Crapez, et al.
Cancers
|
March 6, 2021
Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Florence Boissière-Michot, Ghita Chabab, Caroline Mollevi, et al.
Annals of Surgical Oncology
|
July 17, 2015
Oncoplastic Resection of Breast Cancers Located in the Lower-Inner or Lower-Outer Quadrant with the Modified McKissock Mammaplasty Technique
Pierre-Emmanuel Colombo, Marine Lefèvre, Laure Delmond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 2, 2008
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes
William Jacot, Ludovic Lhermitte, Nadège Dossat, et al.
Page
of 22